tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NTLA Stock Latest News

Citizens JMP healthcare analysts hold an analyst/industry conference
The FlyCitizens JMP healthcare analysts hold an analyst/industry conference
11d ago
BNTC
CRSP
Algonquin, Spotify, Keysight, Intellia, CoreWeave: Trending by Analysts
PremiumWeekend Updates
Algonquin, Spotify, Keysight, Intellia, CoreWeave: Trending by Analysts
14d ago
AQN
CRWV
Intellia Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Intellia Therapeutics Reports Q3 2025 Financial Results
15d ago
NTLA
Midday Fly By: AMD sees acceleration, IBM unveils quantum processor
PremiumThe Fly
Midday Fly By: AMD sees acceleration, IBM unveils quantum processor
17d ago
C
T
Carvana initiated, AT&T upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Carvana initiated, AT&T upgraded: Wall Street’s top analyst calls
17d ago
T
AN
Wolfe downgrades Intellia to Peer Perform on Nex-z safety issue
PremiumThe FlyWolfe downgrades Intellia to Peer Perform on Nex-z safety issue
17d ago
NTLA
Intellia Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research
Premium
The Fly
Intellia Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research
17d ago
NTLA
FDA appoints Richard Pazdur as Director of CDER
Premium
The Fly
FDA appoints Richard Pazdur as Director of CDER
17d ago
AZN
BMY
Intellia Therapeutics downgraded to Hold from Buy at JonesResearch
PremiumThe Fly
Intellia Therapeutics downgraded to Hold from Buy at JonesResearch
18d ago
NTLA
Intellia Therapeutics downgraded to In Line from Outperform at Evercore ISI
PremiumThe Fly
Intellia Therapeutics downgraded to In Line from Outperform at Evercore ISI
18d ago
NTLA
Intellia Reports Favorable Phase 1 Data for Nex-Z
PremiumCompany Announcements
Intellia Reports Favorable Phase 1 Data for Nex-Z
18d ago
8K
NTLA
Intellia announces ‘positive’ follow-up data from ongoing Phase 1 nex-z trial
PremiumThe Fly
Intellia announces ‘positive’ follow-up data from ongoing Phase 1 nex-z trial
18d ago
NTLA
Intellia Therapeutics price target lowered to $14 from $25 at Truist
PremiumThe FlyIntellia Therapeutics price target lowered to $14 from $25 at Truist
19d ago
NTLA
Cathie Wood Sells Tesla (TSLA) Stock, and Buys This Stock after Q3 Beat
Premium
Market News
Cathie Wood Sells Tesla (TSLA) Stock, and Buys This Stock after Q3 Beat
19d ago
TTD
BEAM
Intellia Therapeutics price target lowered to $15 from $18 at H.C. Wainwright
Premium
The Fly
Intellia Therapeutics price target lowered to $15 from $18 at H.C. Wainwright
19d ago
NTLA
Intellia Therapeutics presents Phase 1/2 data on lonvo-z
PremiumThe Fly
Intellia Therapeutics presents Phase 1/2 data on lonvo-z
20d ago
NTLA
Intellia Therapeutics’ Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Intellia Therapeutics’ Earnings Call: Progress Amid Challenges
21d ago
NTLA
Midday Fly By: Musk pay plan approved, ‘GTA VI’ delayed
PremiumThe Fly
Midday Fly By: Musk pay plan approved, ‘GTA VI’ delayed
22d ago
BL
BX
Intellia Therapeutics price target lowered to $9 from $14 at RBC Capital
PremiumThe Fly
Intellia Therapeutics price target lowered to $9 from $14 at RBC Capital
22d ago
NTLA
Intellia Therapeutics price target lowered to $27 from $33 at Oppenheimer
PremiumThe FlyIntellia Therapeutics price target lowered to $27 from $33 at Oppenheimer
22d ago
NTLA
Intellia: Patient who experienced Grade 4 liver safety event has passed away
Premium
The Fly
Intellia: Patient who experienced Grade 4 liver safety event has passed away
22d ago
NTLA
Intellia Therapeutics reports Q3 EPS (92c) vs. ($1.34) last year
Premium
The Fly
Intellia Therapeutics reports Q3 EPS (92c) vs. ($1.34) last year
22d ago
NTLA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >